Contrato Sara Borrell 2022. GOMES MARQUÉS, PATRICE

Datos básicos

Código:
CD22/00045
Protocolo:
CD22/00045
EUDRACT:
NCT:
Centro:
Dotación:
95.000,00 €
Año de incio:
2023
Año de finalización:
2026
RRHH NACIONAL Finan. Competitiva Pública

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

INSTITUTO DE SALUD CARLOS III

Resultados del Ensayo Clínico


Access to liver transplant for women in Spain: a national registry analysis

Tejedor Bravo, Marta; (...); Berenguer, Marina

Meeting Abstract. 2023


Access to liver transplant for women in Spain: a national registry analysis

Tejedor, M.; (...); Berenguer, M.

Meeting Abstract. 2023


Addressing the Burden and Management Strategies for Disparities and Inequities Among Liver Transplant Professionals: The ILTS Experience.

Andacoglu, Oya; (...); Selzner, Nazia

Article. 10.3389/ti.2023.11240. 2023


Anesthesia and Critical Care for the Prediction and Prevention for Small-for-size Syndrome: Guidelines from the ILTS-iLDLT-LTSI Consensus Conference.

Chadha, Ryan; (...); Rela, Mohamed

Article. 10.1097/TP.0000000000004803. 2023


CMV reactivation (rCMV) is associated with lower hepatocellular carcinoma (HCC) recurrence after liver transplatatoin (LT)

Aguilera, V.; (...); Berenguer, M.

Meeting Abstract. 2023


CMV reactivation after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study

Garcia-Garcia, Sonia; (...); Aguilera Sancho, Victoria

Meeting Abstract. 2023


COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls.

Kowdley KV; (...); Villamil A

Article. 10.14309/ajg.0000000000003029. 2024


Correction to COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls.

Kowdley, Kris V; (...); Villamil, Alejandra

Article. 10.14309/ajg.0000000000003153. 2024


Cytomegalovirus reactivation is associated with lower hepatocelullar carcinoma recurrence rates after liver transplantation

Aguilera Sancho, Victoria; (...); Rodriguez-Peralvarez, Manuel

Meeting Abstract. 2023


Cytomegalovirus specific polyfunctional t-cells control CMV reactivation, after liver transplantation

Carvalho-Gomes, Angela; (...); Sancho, Victoria Aguilera

Meeting Abstract. 2024


Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis (vol 22, pg 2062, 2024)

De Vincentis, A.; (...); Conde, Isabel

Correction. 2025


Development and validation of a scoring system to predict response to obeticholic acid in primary biliary cholangitis.

De Vincentis, Antonio; (...); Carbone, Marco

Article. 10.1016/j.cgh.2024.05.008. 2024


Does colectomy improve survival in patients with ulcerative colitis undergoing liver transplant for autoimmune liver diseases?

Trapero-Marugan, M.; (...); Cuervas-Mons, V.

Meeting Abstract. 2023


Early liver transplantation for acute alcoholic hepatitis In a spanish liver transplant center

Aguilera Sancho, Victoria; (...); Berenguer, Marina

Meeting Abstract. 2023


EFFECTIVENESS AND SAFETY OF SECOND-LINE THERAPY IN PRIMARY BILIARY CHOLANGITIS (PBC): A PROSPECTIVE MULTICENTER REAL-WORLD COHORT

Gomez-Dominguez, Elena; (...); Fernandez-Rodriguez, Conrado

Meeting Abstract. 2023


EFFICACY OF OBETICHOLIC ACID (OCA) VS PLACEBO AND EXTERNAL CONTROL (EC) ON CLINICAL OUTCOMES IN PRIMARY BILIARY CHOLANGITIS (PBC)

Kowdley, Kris V.; (...); Villamil, Alejandra

Meeting Abstract. 2023


European Society for Organ Transplantation Consensus Statement on Biomarkers in Liver Transplantation.

Berenguer M; (...); Zubair H

Article. 10.3389/ti.2023.11358. 2023


Excess waitlist mortality and survival benefit of liver transplantation for patients with severe acute-on-chronic liver failure: Interim results of the CHANCE study

Gustot, Thierry; (...); Jalan, Rajiv

Meeting Abstract. 2024


Exchangeable copper for patients with Wilson disease at follow-up: rethinking normal ranges or changing methodology.

Marino, Zoe; (...); Berenguer, Marina

Article. 10.1097/HEP.0000000000001105. 2024


EXCHANGEABLE COPPER QUANTIFICATION FELLS BELOW NORMAL RANGE IN A HIGH PROPORTION OF PATIENTS WITH WILSON DISEASE DURING FOLLOW-UP

Mendez, Zoe Marino; (...); Berenguer, Marina

Meeting Abstract. 2024


Exchangeable copper quantification fells belownormal range in a high proportion of patients withWilson disease during follow-up

Marino, Zoe; (...); Berenguer, Marina

Meeting Abstract. 2024


Exploring pregnancy, breastfeeding and contraception among women with Wilson disease in Spain: results from the Spanish Wilson registry

Romero-Gutierrez, Marta; (...); Marino, Zoe

Meeting Abstract. 2023


External validation of models to predict hepatocellular carcinoma (HCC) in HCV SVR F3-F4 patients

Sahuco, Ivan; (...); Berenguer, Marina

Meeting Abstract. 2023


External validation of models to predict hepatocellular carcinoma in Hepatitis C Virus cured F3-F4 patients.

Carvalho-Gomes Â; (...); Berenguer M

Article. 10.1002/ueg2.12571. 2024


FibroScan compared to liver biopsy for accurately detecting recurrent hepatic steatosis and fibrosis after liver transplantation for metabolic dysfunction-associated steatohepatitis

Martinez-Arenas, Laura; (...); Berenguer, Marina

Meeting Abstract. 2024


FibroScan compared to liver biopsy for accurately detecting recurrent hepatic steatosis and fibrosis after liver transplantation for metabolic dysfunction-associated steatohepatitis

Martinez-Arenas, L.; (...); Berenguer, M.

Meeting Abstract. 2024


FibroScan compared to liver biopsy for accurately staging recurrent hepatic steatosis and fibrosis after transplantation for MASH.

Martinez-Arenas, Laura; (...); Berenguer, Marina

Article. 10.1111/liv.16085. 2024


First nationwide genetic study on Wilson disease (Spanish Wilson registry): high diversity in mutations and in use of genetic evaluation, association with clinical data and influence on diagnosis and health costs

Alonso Castellano, Pablo; (...); Garcia-Villarreal, Luis

Meeting Abstract. 2023


Frailty changes after liver transplantation in the Spanish setting. Results from a Spanish multicentre prospective cohort study

Puchades, L.; (...); Berenguer, M.

Meeting Abstract. 2023


Frailty Changes After Liver Transplantation. Results From a Spanish Multicenter Prospective Cohort Study

Puchades, Lorena; (...); Berenguer, Marina

Article. 10.1097/TXD.0000000000001599. 2024


Gender differences in liver transplantation (LT) for acute liver failure (ALF) in a multicentre ALF-LT Spanish cohort

Conde, Isabel; (...); Aguilera Sancho, Victoria

Meeting Abstract. 2023


Gender differences in liver transplantation (LT) for acute liver failure (ALF) in a multicentre ALF-LT Spanish cohort

Conde, I.; (...); Aguilera, V.

Meeting Abstract. 2023


Health-Related Quality of Life in Patients Living with Wilson Disease in Spain: A Cross-Sectional Observational Study.

Marino, Zoe; (...); Anguera, Anna

Article. 10.3390/jcm12144823. 2023


Hepatic nerve endings are rewired by cholestatic injury to connect inflamed lymphatics to sites of ductular remodelling

Noon, Luke; (...); Lloyd, Alison

Meeting Abstract. 2023


HepatoPredict Accurately Selects Hepatocellular Carcinoma Patients for Liver Transplantation Regardless of Tumor Heterogeneity

Andrade, Rita; (...); Cardoso, Joana

Article. 10.3390/cancers17030500. 2025

  • Open Access.

Impact of suffering Wilson disease in Spain: an observational cross-sectional multicenter study

Marino, Zoe; (...); Anguera, Anna

Meeting Abstract. 2023


Incidence of de novo tumors after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study

Chafer, Isabel Terol; (...); Sancho, Victoria Aguilera

Meeting Abstract. 2023


Incidence of de novo tumors after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study

Chafer, I. Terol; (...); Sancho-Tello, M. V. Aguilera

Meeting Abstract. 2023


International Living Donor Liver Transplant Registry - Initial progress towards transparent reporting of outcomes

Kantsedikas, I.; (...); Rela, M.

Meeting Abstract. 2024


LATTICE radiotherapy: A one institution experience

Solero, I.; (...); Conde, A.

Meeting Abstract. 2023


Launch of the International Living Donor Liver Transplantation Outcomes Registry.

Staubli, Sebastian; (...); Rela, Mohamed

Letter. 10.1016/S2468-1253(23)00185-1. 2023


Lessons from population genomics for Wilson disease: Prevalence, penetrance of mutations, clinical implications and design of regional screening programmes

Alonso Castellano, Pablo; (...); Garcia-Villarreal, Luis

Meeting Abstract. 2023


Liver Transplantation 2023: Status Report, Current and Future Challenges.

Terrault, Norah A; (...); Heimbach, Julie

Article. 10.1016/j.cgh.2023.04.005. 2023


Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice.

Gomez, E; (...); Fernandez-Rodriguez, C M

Article. 10.1111/apt.18004. 2024


Long-term prospective follow-up of a primary biliary cholangitis (PBC) multicenter cohort treated with Obeticholic Acid (OCA). Interaction effect of triple therapy with fibrates

Gomez-Dominguez, Elena; (...); Fernandez-Rodriguez, Conrado

Meeting Abstract. 2023


Low penetrance of frequent ATP7B mutations explains the low prevalence of Wilson disease. Lessons from real-life registries.

Alonso-Castellano, Pablo; (...); Garcia-Villarreal, Luis

Article. 10.1016/j.dld.2024.09.002. 2024


Main clinical characteristics and evolutionary events among patients suffering Wilson disease in Spain: first results from the Spanish Wilson registry

Marino, Zoe; (...); Castillo, Pilar

Meeting Abstract. 2023


Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update.

Ruiz-Arabi, Elisa; (...); Aguado, Jose Maria

Article. 10.1016/j.trre.2024.100875. 2024


Management of Established Small-for-size Syndrome in Post Living Donor Liver Transplantation: Medical, Radiological, and Surgical Interventions: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference.

Kirchner, Varvara A.; (...); Rela, Mohamed

Article. 10.1097/TP.0000000000004771. 2023


Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors

Martin-Mateos, R.; (...); Albillos, A.

Meeting Abstract. 2024


Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors.

Martin-Mateos R; (...); Albillos A

Article. 10.1016/j.jhep.2024.02.023. 2024


Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer.

Deek MP; (...); Sweeney C

Article. 10.1016/j.euo.2024.03.010. 2024


Nutritional status in hepatic encephalopathy and transjugular intrahepatic portosystemic shunt-TIPS, and strategies to improve the outcomes

Berenguer, M.

Review. 10.51821/86.2.11430. 2023


Optimization of treatment in patients with primary biliary cholangitis: Gamma-glutamyl transferase levels as an early prognostic marker for ursodeoxycholic acid response. Results from the ColHai registry

Fernandez-Gordon Sanchez, Flor M.; (...); Gomez-Dominguez, Elena

Meeting Abstract. 2024


Overcoming barriers to care for Delta infected patients

Bono, Ariadna; (...); Berenguer, Marina

Meeting Abstract. 2023


Paediatric solid organ transplant recipients (SOTR) demonstrate greater serological response to initial SARS-CoV-2 vaccination than adult SOTR, and comparable rates of antibody degradation

Pilar Ballester, Maria; (...); Nicastro, Emanuele

Meeting Abstract. 2024


Post Living Donor Liver Transplantation Small-for-size Syndrome: Definitions, Timelines, Biochemical, and Clinical Factors for Diagnosis: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference.

Kow, Alfred Wei Chieh; (...); Ikegami, Toru

Article. 10.1097/TP.0000000000004770. 2023


PREDICTION OF BIOCHEMICAL RESPONSE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS TREATED WITH OBETICHOLIC ACID: DERIVATION AND EXTERNAL VALIDATION OF THE OCA RESPONSE SCORE (ORS)

De Vincentis, Antonio; (...); Carbone, Marco

Meeting Abstract. 2023


Predictive factors for decompensating events in patients with cirrhosis with primary biliary cholangitis under different lines of therapy.

Ampuero J; (...); Fernández-Rodríguez C

Article. 10.1097/HEP.0000000000000826. 2024


Preventing Small-for-size Syndrome in Living Donor Liver Transplantation: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference.

Hakeem AR; (...); Rela M

Article. 10.1097/TP.0000000000004769. 2023


Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice Guideline.

Awan, Ahmed Arslan Yousuf; (...); Jadoul, Michel

Article. 10.7326/M23-2391. 2023


Primary sclerosing cholangitis as an indication for liver transplantation. Results and conditioning factors: relationship with associated intestinal pathology

Fernandez, Ainhoa; (...); Salcedo, Magdalena

Meeting Abstract. 2023


Primary Sclerosing Cholangitis: Gender Effects in Valencia's Low-Prevalence Region.

Minguez, Alejandro; (...); Berenguer, Marina

Article. 10.1007/s10620-024-08368-y. 2024


Profile of plasma microRNAs as a potential biomarker of Wilson's disease.

Sanchez-Monteagudo, Ana; (...); Espinos, Carmen

Article. 10.1007/s00535-024-02135-6. 2024


Prognosticating hepatocellular carcinoma before and after liver transplantation with HepatoPredict

Silva, Silvia Gomes; (...); Cardoso, Joana

Meeting Abstract. 2024


Protocol for an International Living Donor Liver Transplant Registry ! LDLTregistry.org

Turner, B.; (...); Salinas, C. Hidalgo

Meeting Abstract. 2023


Re-irradiation in NSCLC High-dose RT: Control, Survival and Toxicity

Germain, J.; (...); Conde, A.

Meeting Abstract. 2023


Reproductive and pregnancy control in Wilson disease patients in Spain.

Romero-Gutiérrez M; (...); Mariño Z

Article. 10.1097/MEG.0000000000002831. 2024


Risk of decompensated cirrhosis in patients with primary biliary cholangitis under first, second and third-line therapies

Lucena, Ana; (...); Ampuero, Javier

Meeting Abstract. 2023


Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebocontrolled trial

Puente Sanchez, Angela; (...); Garcia Pagan, Juan Carlos

Meeting Abstract. 2023


Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant.

Mehta, Gautam; (...); Jalan, Rajiv

Article. 10.1097/HC9.0000000000000273. 2023


Significant heterogeneity in the diagnosis and long-term management of Wilson disease: Results from a large multicenter Spanish study

Berenguer, Marina; (...); GEMHEP

Article. 10.1016/j.gastrohep.2022.10.018. 2023


Similar rates of liver transplantation (LT) for acute liver failure (ALF) but changes in patient profiles in a Spanish multicentre cohort

Conde, I.; (...); Aguilera, V.

Meeting Abstract. 2023


Survey to evaluate the implementation of the recommendations on the comprehensive diagnosis of viral hepatitis in a single extraction: where are we?

Cabezas, Joaquin; (...); Crespo, Javier

Meeting Abstract. 2023


SURVEY TO EVALUATE THE IMPLEMENTATION OF THE RECOMMENDATIONS ON THE COMPREHENSIVE DIAGNOSIS OF VIRAL HEPATITIS IN A SINGLE EXTRACTION: WHERE ARE WE?

Cabezas, Joaquin; (...); Crespo Garcia, Javier

Meeting Abstract. 2023


The concentration of HDV-RNA correlates with the probability of developing clinical events in patients with chronic hepatitis D

Palom, Adriana; (...); Buti, Maria

Meeting Abstract. 2024


The global prospective observational study to evaluate the role of 'liver transplantation in patients with cirrhosis and severe acute-on-chronic liver failure (CHANCE)': study design, demographics and overall outcome

Gustot, Thierry; (...); Jalan, Rajiv

Meeting Abstract. 2024


Transaminase Pattern Over Time Is Not Associated with a More Aggressive Hepatic Evolution: Results from the AEEH Wilson Registry

Berenguer, Marina; (...); Marino, Zoe

Meeting Abstract. 2024


Transplantation: A Priority in the Healthcare Agenda.

Muller E; (...); Potena L

Article. 10.1097/TP.0000000000005182. 2025


Use of HBsAg-positive donors in liver transplantation: an ILTS-EASLAASLD multisociety survey

Vinaixa, C.; (...); Terrault, N.

Meeting Abstract. 2024


Use of HBsAg-positive donors in liver transplantation: An ILTS-EASL-AASLD multisociety survey.

Vinaixa, Carmen; (...); Berenguer, Marina

Article. 10.1097/LVT.0000000000000432. 2024


Validation of MELD3.0 in 2 centers from different continents.

Tejedor M; (...); Berenguer M

Article. 10.1097/HC9.0000000000000504. 2024


Validation of MELD3.0 in two centres from different continents

Tejedor Bravo, Marta; (...); Berenguer, Marina

Meeting Abstract. 2023


Validation of MELD3.0 in two centres from different continents

Tejedor, M.; (...); Berenguer, M.

Meeting Abstract. 2023


Validation of the liver frailty index as an adverse outcome predictor in the spanish liver transplant setting. Results from a spanish multicentre prospective cohort study.

Puchades, L.; (...); Berenguer, M.

Meeting Abstract. 2023


Variation in global living donor liver transplant surgical technique - early data from the International Living Donor Liver Transplant Registry (LDLTregistry.org)

Kantsedikas, I.; (...); Rela, M.

Meeting Abstract. 2024

  • Open Access.

Variation in global living donor liver transplant surgical technique: Early data from the International Living Donor Liver Transplant Registry

Kantsedikas, Ilya; (...); Rela, Mohamed

Meeting Abstract. 10.1097/01.tp.0001066152.18661.c6. 2024

  • Open Access.

Very low access to early liver transplantation (LT) for acute alcoholic hepatitis (AAH) in a setting of social psychiatric contraindications

Garcia Garcia, S.; (...); Aguilera, V.

Meeting Abstract. 2023


Waiting time dictates impact of frailty: A Spanish multicenter prospective study.

Puchades, Lorena; (...); Berenguer, Marina

Article. 10.1016/j.jhepr.2023.100840. 2023


Women are also disadvantaged in accessing transplant outside the United States: analysis of the spanish liver transplantation registry

Tejedor, Marta; (...); Berenguer, Marina

Meeting Abstract. 2024

  • Open Access.

Women Are Also Disadvantaged in Accessing Transplant Outside the United States: Analysis of the Spanish Liver Transplantation Registry.

Tejedor, Marta; (...); Berenguer, Marina

Article. 10.3389/ti.2024.12732. 2024


Campos de estudio

Compartir